Association of monthly high-dose vitamin D supplementation and cancer risk

0

Bottom Line: Monthly high-dose vitamin D supplementation without calcium for up to four years wasn't associated with reduced cancer risk among adults in New Zealand. This study analyzed data from a randomized clinical trial that included a placebo group. There were 328 total cases of cancer, with 165 among 2,558 participants (6.5 percent) who received monthly high-dose vitamin D supplementation and 163 among 2,550 participants (6.4 percent) in the placebo group. This study suggests monthly high-dose vitamin D supplementation should not be used for cancer prevention.

Authors: Robert Scragg, M.B.B.S., Ph.D., of the University of Auckland, New Zealand, and coauthors

###

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jamaoncol.2018.2178)

Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Want to embed a link to this study in your story?: Links will be live at the embargo time http://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2018.2178

Media Contact

Robert Scragg, M.B.B.S., Ph.D.
[email protected]

@JAMAOnc

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More